Also trades as: HBP.TO (TSX) · $vol 0M
HBPCF OTC
Helix BioPharma Corp.
1W: -55.0%
1M: -55.0%
3M: -55.0%
YTD: -55.5%
1Y: +28.3%
3Y: +6.2%
5Y: -75.2%
$0.77
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$5M
-53256.1% ▼
Net Income
-$5M
-53872.4% ▼
EPS (Diluted)
$0.00
+100.0% ▲
EBITDA
-$5M
-54100.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $173K | $12K | $13K | $0 | $10K |
| Gross Profit | -$173K | -$12K | -$13K | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $6M | $5M | $5M | $6K | $4M |
| SG&A Expenses | $3M | $595K | $1M | $3K | $2M |
| Operating Expenses | $9M | $6M | $6M | $9K | $5M |
| Operating Income | -$10M | -$7M | -$6M | -$9K | -$5M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $15K | $18K | $14K | $0 | $10K |
| Income Before Tax | -$10M | -$7M | -$6M | -$9K | -$5M |
| Tax Expense | $0 | -$484K | $0 | $0 | $0 |
| Net Income | -$8M | -$7M | -$6M | -$9K | -$5M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.06 | $-0.04 | $-0.03 | $-0.00 | $0.00 |
| EBITDA | -$9M | -$7M | -$6M | -$9K | -$5M |
| Shares Outstanding | 138M | 149M | 193M | 111M | 56M |